Stock Split History
ETFs Holding CAPR »    CAPR Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy (DMD), and other rare disorders. Co. is conducting HOPE-2, a Phase II clinical trial in the United States with its product candidate, CAP-1002, a cardiac cell derived therapy which is being used to treat patients with late-stage DMD. Additionally, Co. is developing its exosomes platform technology as a vaccine and therapeutic investigating a variety of disorders. Exosomes act as messengers to regulate the functions of neighboring or distant cells. According to our Capricor Therapeutics stock split history records, Capricor Therapeutics has had 2 splits.
Capricor Therapeutics stock split history picture
Capricor Therapeutics (CAPR) has 2 splits in our Capricor Therapeutics stock split history database. The first split for CAPR took place on November 12, 1997. This was a 1 for 10 reverse split, meaning for each 10 shares of CAPR owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. CAPR's second split took place on June 05, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of CAPR owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 10 share position following the split.

When a company such as Capricor Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the Capricor Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 10 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Capricor Therapeutics shares, starting with a $10,000 purchase of CAPR, presented on a split-history-adjusted basis factoring in the complete Capricor Therapeutics stock split history. Capricor Therapeutics split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/18/2011
End date: 05/17/2021
Start price/share: $5.80
End price/share: $3.87
Dividends collected/share: $0.00
Total return: -33.28%
Average Annual Total Return: -3.96%
Starting investment: $10,000.00
Ending investment: $6,674.60
Years: 10.01
Date Ratio
11/12/19971 for 10
06/05/20191 for 10
CAPR is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CASC Split History
CATB Split History
CBIO Split History
CBLI Split History
CBM Split History
CBMX Split History
CBRX Split History
CCM Split History
CDXC Split History
CELG Split History

Also explore: CAPR shares outstanding history

LM Funding America, Inc. (LMFA)
Foxby Corp. (XFXBX)
InspireMD, Inc. (NSPR)
Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Capricor Therapeutics
Capricor Therapeutics Insider Buying

Capricor Therapeutics Stock Split History | | Copyright © 2013 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.